HALiXPEDITE, Transforming

HALiXPEDITE: Transforming Biologics Therapy Development Programs with Seamless R&D to GMP Integration

Veröffentlicht: 07.08.2025 um 18:08 Uhr, prnewswire.co.uk

Halix B.V. Netherlands United Kingdom United States of America Washington

View original content:https://www.prnewswire.co.uk/news-releases/halixpedite-transforming-biologics-therapy-development-programs-with-seamless-rd-to-gmp-integration-302419685.html

en | boerse | 67926419 |